Treatment of ocular cicatricial pemphigoid with sulfasalazine

Ophthalmology

Volumn 108, Issue 9, 2001, Pages 1565-1568

  Doan, Serge ^a   Lerouic, Jean Francois ^a   Robin, Hervé ^a   Prost, Catherine ^b   Savoldelli, Michelle ^c   Hoang Xuan, Thanh ^a,d  

^a FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔTEL DIEU   (France)

^d Fondation Rothschild   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; DAPSONE; IMMUNOSUPPRESSIVE AGENT; SALAZOSULFAPYRIDINE; SULFAPYRIDINE;

AGED; ARTICLE; AUTOIMMUNITY; BLOOD TOXICITY; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; EYE DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HEMOLYSIS; HUMAN; MALE; MUCOUS MEMBRANE PEMPHIGOID; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOIMMUNE DISEASES; BLOOD CELL COUNT; CHRONIC DISEASE; CONJUNCTIVITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; RETROSPECTIVE STUDIES; SULFASALAZINE; TREATMENT OUTCOME;

EID: 0034862587     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(01)00657-1     Document Type: Article

References (20)

1. Cicatricial pemphigoid
2. Azathioprine in the treatment of mucocutaneous pemphigoid
3. Systemic chemotherapy for ocular cicatricial pemphigoid
4. Benign mucous membrane pemphigoid. Response to therapy with cyclophosphamide
5. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone
6. Sulfapyridine - A new agent for the treatment of ocular cicatricial pemphigoid
7. Salazopyrine: A new sulfanilamide preparation
8. Improved detection of disease progression in ocular cicatricial pemphigoid
9. Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid
10. Cicatricial pemphigoid
11. Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid
12. Sulphasalazine: A review of 40 years' experience
13. Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis
14. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenyl-alanine by sulfones
15. Sulfasalazine improves psoriasis. A double-blind analysis
16. Generalized morphoea successfully treated with Salazopyrine
17. Traitement du lupus erythemateux chronique par la sulfasalazine: 11 Observations
18. Treatment of ankylosing spondylitis with salazosulfapyridine. A controlled double-blind study in 60 patients
19. The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis
20. Tolerability of enteric-coated sulphasalazine in rheumatoid arthritis: Results of a co-operating clinics study